About
Team
Investors
Stock Information
Press Releases
Events & Presentations
SEC Filings
Corporate Governance
Shareholder Services
Analyst Coverage
Pipeline
Lonafarnib / Ritonavir for Hepatitis Delta Virus (HDV) Infection
Peginterferon Lambda for Hepatitis Delta Virus (HDV) Infection
Avexitide for Post-Bariatric Hypoglycemia (PBH)
Avexitide for Congenital Hyperinsulinism (CHI)
ZOKINVY™
Resources
Expanded Access Policy
Contact Us
Privacy Policy
Terms and Conditions
Careers
About
Team
Investors
Stock Information
Press Releases
Events & Presentations
SEC Filings
Corporate Governance
Shareholder Services
Analyst Coverage
Pipeline
Lonafarnib / Ritonavir for Hepatitis Delta Virus (HDV) Infection
Peginterferon Lambda for Hepatitis Delta Virus (HDV) Infection
Avexitide for Post-Bariatric Hypoglycemia (PBH)
Avexitide for Congenital Hyperinsulinism (CHI)
ZOKINVY™
Resources
Expanded Access Policy
Contact Us
Privacy Policy
Terms and Conditions
Careers
Pipeline
Eiger is focused on the development and commercialization of first-in-class, well-characterized drugs for serious rare and ultra-rare diseases for patients with highly unmet medical needs.
First-In-Class Therapies of Patients In Need
(Swipe to interact)
Modal Template